Stress Ulcer Prophylaxis

  • Paul Ellis Marik


In 1969, Skillman and colleagues reported a clinical syndrome of lethal stress ulceration in 7 of 150 (5%) consecutive ICU patients. These patients had in common respiratory failure, hypotension, and sepsis.1 Pathological examination demonstrated multiple superficial ulcers which were confined to the gastric fundus. Following this report, these authors performed a randomized controlled study in which 100 critically ill ICU patients at risk of “stress ulceration” were randomized to either antacid prophylaxis (titrated to keep the gastric pH above 3.5) or no prophylaxis.2 Two of 51 (4%) treated patients had gastrointestinal bleeding (GIB) as compared to 12 of 49 (25%) control patients (p <0.005).


Enteral Nutrition Mucosal Blood Flow Stress Ulcer Prophylaxis Early Enteral Nutrition Jejunostomy Feeding Tube 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Skillman JJ, Bushnell LS, Goldman H, et al. Respiratory failure, hypotension, sepsis and jaundice: a clinical syndrome associated with lethal haemorrhage from acute stress ulceration of the stomach. Am J Surg. 1969;117:523–530.PubMedCrossRefGoogle Scholar
  2. 2.
    Hastings PR, Skillman JJ, Bushnell LS, et al. Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients. N Engl J Med. 1978;298:1041–1045.PubMedCrossRefGoogle Scholar
  3. 3.
    Cook DJ, Witt LG, Cook RJ, et al. Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med. 1991;1991:519–527.CrossRefGoogle Scholar
  4. 4.
    Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996;275:308–314.PubMedCrossRefGoogle Scholar
  5. 5.
    Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2008;36:296–327.PubMedCrossRefGoogle Scholar
  6. 6.
    American Society of Hospital Pharmacists therapeutic guidelines on stress ulcer prophylaxis. Am J Health System Pharm. 1999;56:347–379.Google Scholar
  7. 7.
    Quality Measures Compendium. Division of Quality, Evaluation and Health Outcomes, Centers for Medicare and Medicaid Services. Available at 2. 2007. Accessed March 13, 2009.
  8. 8.
    Jung R, MacLaren R. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients. Ann Pharmacother. 2002;36:1929–1937.PubMedCrossRefGoogle Scholar
  9. 9.
    Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology. 2004;51:757–761.PubMedGoogle Scholar
  10. 10.
    Fisher RL, Pipkin GA, Wood JR. Stress-related mucosal disease. Pathophysiology, prevention and treatment. Crit Care Clin. 1995;11:323–345.PubMedGoogle Scholar
  11. 11.
    Eddleston JM, Pearson RC, Holland J, et al. Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo. Crit Care Med. 1994;22:1949–1954.PubMedGoogle Scholar
  12. 12.
    Martin LF. Stress ulcers are common after aortic surgery. Endoscopic evaluation of prophylactic therapy. Am Surg. 1994;60:169–174.PubMedGoogle Scholar
  13. 13.
    Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994;330:377–381.PubMedCrossRefGoogle Scholar
  14. 14.
    Messori A, Trippoli S, Vaiani M, et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ. 2000;321:1103–1106.PubMedCrossRefGoogle Scholar
  15. 15.
    Zandstra DF, Stoutenbeek CP. The virtual absence of stress-ulceration related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis. A prospective cohort study. Intensive Care Med. 1994;20:335–340.PubMedCrossRefGoogle Scholar
  16. 16.
    Erstad BL, Camamo JM, Miller MJ, et al. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center. Crit Care Med. 1997;25:1678–1684.PubMedCrossRefGoogle Scholar
  17. 17.
    Faisy C, Guerot E, Diehl JL, et al. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis. Intensive Care Med. 2003;29:1306–1313.PubMedCrossRefGoogle Scholar
  18. 18.
    Pingleton SK, Hadzima SK. Enteral alimentation and gastrointestinal bleeding in mechanically ventilated patients. Crit Care Med. 1983;11:13–16.PubMedCrossRefGoogle Scholar
  19. 19.
    Ephgrave KS, Kleiman-Wexler RL, Adair CG. Enteral nutrients prevent stress ulceration and increase intragastric volume. Crit Care Med. 1990;18:621–624.PubMedCrossRefGoogle Scholar
  20. 20.
    Shorr LD, Sirinek KR, Page CP, et al. The role of glucose in preventing stress gastric mucosal injury. J Surg Res. 1984;36:384–388.PubMedCrossRefGoogle Scholar
  21. 21.
    Bonten MJ, Gaillard CA, van Tiel FH, et al. Continuous enteral feeding counteracts preventive measures for gastric colonization in intensive care unit patients. Crit Care Med. 1994;22:939–944.PubMedCrossRefGoogle Scholar
  22. 22.
    Mabogunje OA, Andrassy RJ, Isaacs H Jr, et al. The role of a defined formula diet in the prevention of stress-induced gastric mucosal injury in the rat. J Pediatr Surg. 1981;16:1036–1039.PubMedCrossRefGoogle Scholar
  23. 23.
    Lally KP, Andrassy RJ, Foster JE, et al. Evaluation of various nutritional supplements in the prevention of stress-induced gastric ulcers in the rat. Surg Gynecol Obstet. 1984;158:124–128.PubMedGoogle Scholar
  24. 24.
    Raff T, Germann G, Hartmann B. The value of early enteral nutrition in the prophylaxis of stress ulceration in the severely burned patient. Burns. 1997;23:313–318.PubMedCrossRefGoogle Scholar
  25. 25.
    Cheadle WG, Vitale GC, Mackie CR, et al. Prophylactic postoperative nasogastric decompression. A prospective study of its requirement and the influence of cimetidine in 200 patients. Ann Surg. 1985;202:361–366.PubMedCrossRefGoogle Scholar
  26. 26.
    Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study. Ann Intern Med. 1994;121:568–575.PubMedGoogle Scholar
  27. 27.
    Apte NM, Karnad DR, Medhekar TP, et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med. 1992;20:590–593.PubMedCrossRefGoogle Scholar
  28. 28.
    MacLaren R, Jarvis CL, Fish DN. Use of enteral nutrition for stress ulcer prophylaxis. Ann Pharmacother. 2001;35:1614–1623.PubMedCrossRefGoogle Scholar
  29. 29.
    Valentine RJ, Turner WW, Borman K, et al. Does nasoenteral feeding afford adequate gastroduodenal stress prophylaxis? Crit Care Med. 1986;14:599–601.PubMedCrossRefGoogle Scholar
  30. 30.
    Artinian V, Krayem H, DiGiovine B. Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest. 2006;129:960–967.PubMedCrossRefGoogle Scholar
  31. 31.
    Marik PE, Pinsky MR. Death by total parenteral nutrition. Intensive Care Med. 2003;29:867–869.PubMedGoogle Scholar
  32. 32.
    de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360(1):20–31.PubMedCrossRefGoogle Scholar
  33. 33.
    Chan EY, Ruest A, O’Meade M, et al. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systemic review and meta-analysis. Br Med J. 2007;-doi:10.1136/bmj.39136.528160.BE.Google Scholar
  34. 34.
    Herzig SJ, Howell MD, Ngo LH, et al. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009;301:2120–2128.PubMedCrossRefGoogle Scholar
  35. 35.
    Cunningham R, Dale B, Undy B, et al. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54:243–245.PubMedCrossRefGoogle Scholar
  36. 36.
    Dial S, Alrasadi K, Manoukian C, et al. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004;171:33–38.PubMedCrossRefGoogle Scholar
  37. 37.
    Louie TJ, Meddings J. Clostridium difficile infection in hospitals: risk factors and responses. CMAJ. 2004;171:45–46.PubMedCrossRefGoogle Scholar
  38. 38.
    Dial S, Delaney JA, Barkun AN et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294:2989–2995.PubMedCrossRefGoogle Scholar
  39. 39.
    Segal R, Russell WL, Oh T, et al. Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals. Am J Hosp Pharm. 1993;50:2077–2081.PubMedGoogle Scholar
  40. 40.
    Ben-Joseph R, Segal R, Russell WL. Risk for adverse events among patients receiving intravenous histamine-2-receptor antagonists. Ann Pharmacother. 1993;27:1532–1537.PubMedGoogle Scholar
  41. 41.
    Cantu TG, Korek JS. Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med. 1991;114:1027–1034.PubMedGoogle Scholar
  42. 42.
    Cerra FB, Schentag JJ, McMillen M, et al. Mental status, the intensive care unit and cimetidine. Ann Surg. 1982;196:565–570.PubMedCrossRefGoogle Scholar
  43. 43.
    Welage LS, Wing PE, Schentag JJ, et al. An evaluation of intravenous famotidine (F) versus cimetidine (C) therapy in the critically ill. Gastroenterology. 1988;94:A491.Google Scholar
  44. 44.
    Kim KA, Park PW, Hong SJ, et al. The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance. Clin Pharmacol Ther. 2008;84:236–242.PubMedCrossRefGoogle Scholar
  45. 45.
    Li XQ, Andersson TB, Ahlstrom M, et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos. 2004;32:821–827.PubMedCrossRefGoogle Scholar
  46. 46.
    Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;301:937–944.PubMedCrossRefGoogle Scholar
  47. 47.
    Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180:713–718.PubMedCrossRefGoogle Scholar
  48. 48.
    Mulla H, Peek G, Upton D, et al. Plasma aluminum levels during sucralfate prophylaxis for stress ulceration in critically ill patients on continuous venovenous hemofiltration: a randomized, controlled trial. Crit Care Med. 2001;29:267–271.PubMedCrossRefGoogle Scholar
  49. 49.
    Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338:791–797.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care MedicineEastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations